78940-73-5 Usage
Molecular weight
288.72 g/mol The molecular weight of 2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZONITRILE is 288.72 g/mol, which indicates the mass of one mole of the compound.
Yellow crystalline solid 2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZONITRILE is a yellow crystalline solid, which describes its physical appearance and state.
Common uses
Synthesis of pharmaceuticals, agrochemicals, and dyes 2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZONITRILE is commonly used in the synthesis of various pharmaceuticals, agrochemicals, and dyes, which indicates its applications in different industries.
Potential properties
Antimicrobial and antifungal 2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZONITRILE has been studied for its potential antimicrobial and antifungal properties, which indicates its possible uses in treating infections.
Chemical research
Building block for complex organic molecules 2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZONITRILE is used in chemical research as a building block for the preparation of other complex organic molecules, which indicates its importance in the field of chemistry.
Safety concerns
Harmful effects on human health and environment It is important to handle 2-[(4-CHLOROPHENYL)THIO]-5-NITROBENZONITRILE with care, as it may have harmful effects on human health and the environment, which indicates the need for proper safety precautions.
Check Digit Verification of cas no
The CAS Registry Mumber 78940-73-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,8,9,4 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 78940-73:
(7*7)+(6*8)+(5*9)+(4*4)+(3*0)+(2*7)+(1*3)=175
175 % 10 = 5
So 78940-73-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H7ClN2O2S/c14-10-1-4-12(5-2-10)19-13-6-3-11(16(17)18)7-9(13)8-15/h1-7H
78940-73-5Relevant articles and documents
Substituted benzonitriles having antiviral activity
-
, (2008/06/13)
Substituted benzonitriles having antiviral activity are disclosed. Methods of use based on the antiviral activity of the compounds are also disclosed, as well as compositions which comprise a carrier in combination with a suitable antiviral active compoun
Xn:Harmful;
